𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Long-term follow-up of patients with hepatitis B e antigen negative chronic hepatitis B

✍ Scribed by Dan Bekku; Makoto Arai; Fumio Imazeki; Yutaka Yonemitsu; Tatsuo Kanda; Keiichi Fujiwara; Kenichi Fukai; Kenichi Sato; Sakae Itoga; Fumio Nomura; Osamu Yokosuka

Book ID
108953746
Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
316 KB
Volume
26
Category
Article
ISSN
0815-9319

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of lamivudine in patients with
Efficacy of lamivudine in patients with hepatitis B e antigen–negative/hepatitis B virus DNA–positive (precore mutant) chronic hepatitis befficacy of lamivudine in patients with hepatitis B e antigen–negative/hepatitis B virus DNA–positive (precore mutant) chronic hepatitis befficacy of lamivudine in patients with hepatitis B e antigen–negative/hepatitis B virus DNA–positive (precore mutant) chronic hepatitis befficacy of lamivudine in patients with hepatitis B e antigen–negative/hepatitis B virus DNA–positive (precore mutant) chronic hepatitis BB
✍ Nicolaos C. Tassopoulos; Riccardo Volpes; Giuseppe Pastore; Jenny Heathcote; Mar 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB 👁 1 views

This placebo controlled, double-blind study evaluated the efficacy and safety of lamivudine in patients with hepatitis B e antigen (HBeAg)-negative/hepatitis B virus (HBV) DNA-positive chronic hepatitis B. Patients were randomized to receive 100 mg lamivudine orally once daily for 52 weeks (n ‫؍‬ 60

Hepatitis B and D genomes in hepatitis B
Hepatitis B and D genomes in hepatitis B surface antigen negative patients with chronic hepatitis C
✍ Sara González; Sonia Navas; Antonio Madejón; Javier Bartolomé; Inmaculada Castil 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 607 KB

## Abstract Hepatitis B and hepatitis D viral genomes were tested by nested polymerase chain reaction in the serum and liver of 69 hepatitis B surface antigen (HBsAg) negative, anti‐hepatitis C virus (HCV) positive patients (47 with HCV RNA and 22 without HCV RNA). Serum hepatitis B virus (HBV) DNA

Outcome of hepatitis B e antigen–negativ
Outcome of hepatitis B e antigen–negative chronic hepatitis B on long-term nucleos(t)ide analog therapy starting with lamivudine
✍ George V. Papatheodoridis; Evangelini Dimou; Konstantinos Dimakopoulos; Spilios 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 415 KB 👁 1 views

We determined the clinical outcome of hepatitis e antigen (HBeAg)-negative chronic hepatitis B patients treated with long-term nucleos(t)ide analog therapy starting with lamivudine. We evaluated 201 such patients treated for 3.8 ؎ 1.4 years and 2 historical similar cohorts: 1 treated with interferon